Aurobindo Pharma

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue7,9328,1368,5177,9738,406
Expenses6,7256,9387,1506,7697,132
EBITDA1,7021,7351,9271,7081,799
EBIT1,3201,3181,4501,3051,371
Profit Before Tax1,2071,2001,3351,2071,276
Net Profit816.95845.57902.83824.20848.13
Financial Ratios
Operating Profit Margin22.27%22.00%22.60%21.95%21.86%
Net Profit Margin10.69%10.72%10.78%10.58%10.30%
Earning Per Share (Diluted)14.0014.5615.5614.2014.61
Dividends Per Share0.000.000.004.000.00